Comprehensive Suite Of In Vivo And In Vitro Services

Labcorp offers a comprehensive suite of in vivo and in vitro services to enable the development of human and veterinary vaccines against viral and bacterial pathogens. They work with all common vaccine types, including subunit, live/attenuated, inactivated viruses and bacteria, DNA/RNA, and toxoid.

Their broad end-to-end service offering can take a vaccine from discovery to Investigational New Drug (IND) submission, providing cost and time savings through efficient project management and scientific expertise. Services include non-GLP toxicology, immunogenicity, dose-response, and efficacy studies.

Immunogenicity studies combine in vivo and in vitro services for a complete evaluation, including host species selection and dose optimization. Efficacy/challenge studies follow satisfactory immunogenicity results, utilizing standard or custom animal models in vivariums supporting up to BSL2 pathogens. Discover the full range of expertise and capabilities available for your vaccine development needs.